전체 8345
-
- Stress in the Workplace (NIH Only)
-
- - Dr. Michael Bowler (2012/01/27)
- - Category : Occupational Health & Safety Lectures (NIH Only)
- Division of Occupation Health and Safety Lecture Series
The Division of Occupational Health (DOHS) Employee Assistance Program (EAP) offers services that can help you navigate through the different stresses. Mr. Michael Bowler will discuss different ways to deal with stress in the workplace.
Michael Bowler received his Masters in Social work from Boston College with a specialization in community mental health. He received his Doctorate in Social Work Research from Washington University in St. Louis with a specialty in the social psychology of health behavior. Dr. Bowler received an additional Master？？？s degree in Organizational Development from Johns Hopkins University, and earned a Certificate in Conflict Management in the Workplace from American University and a Certificate in Coaching in the Workplace from Georgetown University. Prior to coming to NIH, he was on the faculty of George Mason University and the Johns Hopkins School of Health Services. The seminar series is sponsored by the Office of Research Services, Division of Occupational Health and Safety (DOHS), in partnership with the Division of Amenities and Transportation Services Wellness Program.
Stress in the Workplace (NIH Only)
-
- Regenerative Medicine: Current Concepts and Changing Trends
-
- - Anthony Atala, M.D., Wake Forest School of Medicine (2012/01/27)
- - Category : Wednesday Afternoon Lectures
- Patients with diseased or injured organs may be treated with transplanted organs. There is a severe shortage of donor organs which is worsening yearly due to the aging population. Regenerative medicine and tissue engineering apply the principles of cell transplantation, material sciences, and bioengineering to construct biological substitutes that may restore and maintain normal function in diseased and injured tissues. Stem cells may offer a potentially limitless source of cells for tissue engineering applications and are opening new options for therapy. Recent advances that have occurred in regenerative medicine will be reviewed and applications of these new technologies that may offer novel therapies for patients with end-stage tissue and organ failure will be described.
The NIH Wednesday Afternoon Lecture Series includes weekly scientific talks by some of the top researchers in the biomedical sciences worldwide.
For more information, visit:
The NIH Directors Wednesday Afternoon Lecture Series
Regenerative Medicine: Current Concepts and Changing Trends
-
- The role of orbitofrontal cortex in reinforcement learning and addiction
-
- - Goeffrey Schoenbaum, MD, PhD, NIDA IRP, Chief, Cellular Neurobiology Research Branch (2012/01/26)
- - Category : Neuroscience
- Neuroscience Seminar Series
The Schoenbaum lab studies how the orbitofrontal cortex cooperates with other brain areas to guide adaptive decision-making. Evidence suggests that the ability to form and use information about outcomes depends critically upon processing in a circuit of brain regions including the orbitofrontal cortex (OFC), basolateral amygdala (ABL) and nucleus accumbens (NA). By studying how these brain areas mediate goal-directed behavior in rats, we can understand how the same circuit functions in humans. More importantly, they can also use our model to study how the normal function of this circuit is disrupted in clinical brain disorders and how treatments might address this disruption. In addition, the Schoenbaum lab has used this work as background to study changes in decision-making in addiction and aging.
For more information, visit: http://neuroseries.info.nih.gov
The role of orbitofrontal cortex in reinforcement learning and addiction
-
- Will Dendritic Cell Subsets Help Us Address the Challenges of Cancer, Autoimmunity and Chronic Viral Diseases?
-
- - Dr. Jacques Banchereau, Hoffmann-La Roche Inc. (2012/01/26)
- - Category : Wednesday Afternoon Lectures
- Jacques Banchereau, PhD, is Head of both the Inflammation and the Virology Discovery and Translational Areas (DTA) and Chief Scientific Officer for Hoffmann-La Roche Inc. (Roche), in Nutley, New Jersey. In this role, he oversees research and early development up to late stage development in the field of Inflammation, including autoimmune and respiratory diseases and in Virology, including hepatitis, influenza and other infectious diseases. As Nutleys Chief Scientific Officer, his mission is to drive scientific excellence and scientific exchange on the Nutley site.
Jacques joined Roche in 2010 from the Baylor Institute for Immunology Research in Dallas, Texas, where he was the Founder and Director. The Institute was designed on the concept of studying patients suffering from diseases that involve the immune system. During his tenure, Jacques orchestrated the Institutes growth, building a broad human immunology research portfolio by applying a multi-disciplinary approach and actively securing large grants to fund research activities. The Institute also hosts the INSERM Unit U899, specialized in human vaccines. Jacques oversaw the construction of a new Institute, which includes GMP facilities for the production of cells destined to be re-injected to patients. His research group was the first to discover how to grow human dendritic cells, an important breakthrough that led to the better understanding of autoimmune disorders, like lupus, and to the development of dendritic cell-based immunotherapy.
With ongoing collaborations between Roche and Baylor Institute, Jacques continues to oversee the work in translational research spanning diseases such as cancer (melanoma, breast cancer), autoimmunity (arthritis, lupus) and infectious diseases (HIV, HCV and Influenza).
After graduating as a pharmacist from University of Angers, France, Jacques transferred to the University of Paris, earning certification in pharmacology and immunology, as well as clinical biochemistry, microbiology, and parasitology, before completing a PhD in biochemistry. During his PhD studies, he spent one year as a research fellow at Columbia University in New York. One year later, Jacques joined Schering Ploughs research unit in Dardilly, France - the beginning of a highly productive 15-year career including the understanding of the biology and therapeutic potential of numerous cytokines.
As a result of 30 years experience in discovery and translational science, in industry and academia, Jacques is recognized as a world-class leader in immunological research encompassing a vast array of clinical conditions triggered by immunological anomalies and mechanisms. He is inventor or co-inventor on numerous patents and a widely published author.
The NIH Wednesday Afternoon Lecture Series includes weekly scientific talks by some of the top researchers in the biomedical sciences worldwide.
For more information, visit:
The NIH Directors Wednesday Afternoon Lecture Series
Will Dendritic Cell Subsets Help Us Address the Challenges of Cancer, Autoimmunity and Chronic Viral Diseases?
-
- STEP - Tomorrows Scientists: Will they be prepared in 2050? (HHS-Only)
-
- - Charisee Lamar (2012/01/26)
- - Category : STEP (HHS Only)
- New epidemics, new sources of energy, new interventions -- who will meet future challenges? Our children and our children's children; but will they be ready? Only if we engage them and maintain their interest in Science, Technology, Engineering and Math (STEM). Come join us as we examine the role of NIH, educators, and the public in training scientists for the 21st Century.
For more information go to http://nih-extramural-intranet.od.nih.gov/nih/training/step/step_training_20120124.htm
STEP - Tomorrows Scientists: Will they be prepared in 2050? (HHS-Only)
-
- Demystifying Medicine- Parkinsons Disease: from genetics to surgery
-
- - Codrin Lungu, Kareem Zaghloul (2012/01/26)
- - Category : Demystifying Medicine
- The course includes presentation of patients, pathology, diagnosis and therapy in the context of major disease problems and current research. Primarily directed toward Ph.D. students, fellows, and staff, it is also of interest to medical students and clinicians. The course is designed to help bridge the gap between advances in biology and their application to major human diseases. Each session includes clinical and basic science components which are presented by NIH staff and outside invitees.
For more information go to http://demystifyingmedicine.od.nih.gov/
Demystifying Medicine- Parkinsons Disease: from genetics to surgery
-
- Orloff Science Awards 2012 (NIH Only)
-
- - Robert S. Balaban (2012/01/25)
- - Category : NIH Only
- The Division of Intramural Reseach will provide service awards for excellence in research and adminstrative services on January 20, 2012
Orloff Science Awards 2012 (NIH Only)
-
- Basic and Translational Research on Saliva from Insect Vectors of Neglected Diseases: From Pharmacology to Biomarkers and Vaccines
-
- - Jesus Valenzuela (2012/01/24)
- - Category : NIH Directors Seminars
- NIH Directors Seminar Series
For more information, visit: http://www.nih.gov/about/director/dirsem.htm
Basic and Translational Research on Saliva from Insect Vectors of Neglected Diseases: From Pharmacology to Biomarkers and Vaccines
-
- CC Grand Rounds: Ankylosing Spondylitis in 2012: From Genetic Discovery to Better Outcome
-
- - (1) Robert A. Colbert, MD, PhD, Senior Investigator and Chief, Pediatric Translational Research Branch, NIAMS (2)Michael M.Ward, MD, Senior Investigator, Office of the Clinical Director, Intramural Research Program, NIAMS (2012/01/21)
- - Category : Clinical Center Grand Rounds
- Ankylosing Spondylitis
CC Grand Rounds: Ankylosing Spondylitis in 2012: From Genetic Discovery to Better Outcome
-
- The 8th NIH GIST Clinic Invitational Lecture 2012
-
- - Fernanda Arnaldez (2012/01/21)
- - Category : Special
- The 8th NIH GIST Clinic Invitational Lecture will feature updates and future plans from the NIH Pediatric and Wildtype GIST Clinic
For more information go to http://www.pediatricgist.cancer.gov/
The 8th NIH GIST Clinic Invitational Lecture 2012
-
- OHR Brown Bag Session: Birth Order: Whats it Got to Do With Business? (NIH Only)
-
- - Jack Agati (2012/01/21)
- - Category : Human Resources (NIH Only)
- Professional Development
OHR Brown Bag Session: Birth Order: Whats it Got to Do With Business? (NIH Only)
-
- OHR All Hands Meeting - January 2012 (NIH Only)
-
- - OHR (2012/01/19)
- - Category : Human Resources (NIH Only)
- Please join OHR Leadership to recap OHR？？？s 2011 accomplishments.
OHR All Hands Meeting - January 2012 (NIH Only)
-
- NBBTP Class of 2011 Graduation
-
- - DOHS (2012/01/19)
- - Category : Special
- NBBTP 2011 Graduation activites and recognition to mentors of the fellows for their service.
NBBTP Class of 2011 Graduation
-
- Infection Prevention: An Interdisciplinary Team Approach
-
- - Dr. Elaine Larson, Columbia University (2012/01/19)
- - Category : Special
- This is the 2012 NINR Director？？？s Lecture, ？？？Infection Prevention: An Interdisciplinary Team Approach.？？？ The lecture will be given by Dr. Elaine Larson, a member of the National Advisory Council for Nursing Research, who will discuss her globally recognized research in infection prevention and control.
Dr. Larson is the Associate Dean for Research and Professor of Pharmaceutical and Therapeutic Research at the Columbia University School of Nursing and a Professor of Epidemiology at the Columbia University Mailman School of Public Health. She is a fellow in the Institute of Medicine and has published more than 250 journal articles, four books and a number of book chapters in the areas of infection prevention, epidemiology, and clinical research. The NINR Director？？？s Lecture is designed to bring the nation？？？s top nurse scientists to the NIH campus to share their work and interests with a trans-disciplinary audience. This is the second annual NINR Director？？？s Lecture.
For more information go to http://www.ninr.nih.gov/directorslecture
Infection Prevention: An Interdisciplinary Team Approach
-
- Demystifying Medicine - Stem Cells: new frontier in biology and medicine
-
- - Mahendra Rao, Ronald Gress (2012/01/19)
- - Category : Demystifying Medicine
- The course includes presentation of patients, pathology, diagnosis and therapy in the context of major disease problems and current research. Primarily directed toward Ph.D. students, fellows, and staff, it is also of interest to medical students and clinicians. The course is designed to help bridge the gap between advances in biology and their application to major human diseases. Each session includes clinical and basic science components which are presented by NIH staff and outside invitees.
For more information go to http://demystifyingmedicine.od.nih.gov/
Demystifying Medicine - Stem Cells: new frontier in biology and medicine
-
- The Development and Evaluation of Human Cytomegalovirus Vaccines; Public Workshop (Day 2)
-
- - The Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER), the National Institutes of Health, the National Institute of Allergy and Infectious Diseases (NIAID), the Centers for Disease Control and Prevention and the National Vaccine Program Office (2012/01/18)
- - Category : Conferences
- The public workshop will focus on the status of knowledge about HCMV biology and epidemiology and on vaccine development strategies. Topics for discussion will include: (1) HCMV epidemiology and diagnosis, (2) HCMV immunology and virology, (3) manufacturers' and regulators' perspectives, (4) target populations for a HCMV vaccine, (5) design of clinical trials to study HCMV vaccines in the setting of congenital HCMV and transplants, and (6) next steps toward development of HCMV vaccines.
The Development and Evaluation of Human Cytomegalovirus Vaccines; Public Workshop (Day 2)
-
- Contemporary Clinical Medicine: Great Teachers: Controversies in the Management of Low Back Pain
-
- - Richard A. Deyo, MD, MPH, Kaiser Permanente Professor of Evidence-Based Family Medicine, Orgeon Health and Science University and Director, Community and Practice-Based Research Program, Oregon Clinical and Translational Research Institute (2012/01/18)
- - Category : Clinical Center Grand Rounds
- Management of Low Back Pain
Contemporary Clinical Medicine: Great Teachers: Controversies in the Management of Low Back Pain
-
- NIH 2012 Dr. Martin Luther King, Jr. Observance Program (NIH Only)
-
- - Lemuel T. Russell IV, Ph.D., the United States Environmental Protection Agency (USEPA) (2012/01/15)
- - Category : Black History Observance (NIH Only)
- Join us for the NIH 2012 Dr. Martin Luther King, Jr. Observance Program. After a long struggle, legislation was signed in 1983 creating a Federal holiday marking the birthday of Rev. Dr. Martin Luther King, Jr.. The Federal holiday was first observed in 1986, this year marks the 26th anniversary of the King Federal holiday. In 1994, Congress designated the Martin Luther King Jr. Federal Holiday as a national day of service.
The keynote speaker Lemuel T. Russell IV, Ph.D., is a Regulatory Mammalian Toxicologist for the United States Environmental Protection Agency (USEPA). Dr. Russell works in the New Chemicals Safety and Assessment Branch (NCSAB) Risk Assessment Division (RAD) of the USEPA. He provides risk and safety evaluation of industrial chemicals under safety and risk assessment in the new and existing chemicals program at the USEPA.
The Duke Ellington School of the Arts will also perform.
Other program participants include Francis Collins, M.D., Ph.D., Director, NIH; Roland Owens, Ph.D., Assistant Director, Office of Intramural Research, NIH; and Sheila Stokes, Esq., Acting Director, Office of Equal Opportunity and Diversity Management, NIH.
NIH 2012 Dr. Martin Luther King, Jr. Observance Program (NIH Only)
-
- Demystifying Medicine-Global Infections the great challenges
-
- - Anthony Fauci, John Coffin (2012/01/14)
- - Category : Demystifying Medicine
- The course includes presentation of patients, pathology, diagnosis and therapy in the context of major disease problems and current research. Primarily directed toward Ph.D. students, fellows, and staff, it is also of interest to medical students and clinicians. The course is designed to help bridge the gap between advances in biology and their application to major human diseases. Each session includes clinical and basic science components which are presented by NIH staff and outside invitees.
For more information go to http://demystifyingmedicine.od.nih.gov/
Demystifying Medicine-Global Infections the great challenges
-
- The Development and Evaluation of Human Cytomegalovirus Vaccines; Public Workshop (Day 1)
-
- - The Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER), the National Institutes of Health, the National Institute of Allergy and Infectious Diseases (NIAID), the Centers for Disease Control and Prevention and the National Vaccine Program Office (2012/01/13)
- - Category : Conferences
- The public workshop will focus on the status of knowledge about HCMV biology and epidemiology and on vaccine development strategies. Topics for discussion will include: (1) HCMV epidemiology and diagnosis, (2) HCMV immunology and virology, (3) manufacturers' and regulators' perspectives, (4) target populations for a HCMV vaccine, (5) design of clinical trials to study HCMV vaccines in the setting of congenital HCMV and transplants, and (6) next steps toward development of HCMV vaccines.
The Development and Evaluation of Human Cytomegalovirus Vaccines; Public Workshop (Day 1)